{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"Aborder les enjeux complexes du glioblastome multiforme - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"QXHSdkS0x5\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2010\/11\/18\/15e-reunion-scientifique-annuelle-de-la-society-2\/\">Aborder les enjeux complexes du glioblastome multiforme<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2010\/11\/18\/15e-reunion-scientifique-annuelle-de-la-society-2\/embed\/#?secret=QXHSdkS0x5\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Aborder les enjeux complexes du glioblastome multiforme\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"QXHSdkS0x5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2010\/11\/sno_graph1_fr.png","thumbnail_width":792,"thumbnail_height":570,"description":"Montr&eacute;al &ndash; Une &eacute;nergie et des ressources consid&eacute;rables sont d&eacute;ploy&eacute;es en recherche afin d&rsquo;am&eacute;liorer l&rsquo;issue des glioblastomes multiformes nouvellement diagnostiqu&eacute;s ou r&eacute;cidivants. Les pr&eacute;sentations dont il est question ci-apres t&eacute;moignent de l&rsquo;efficacit&eacute; et de l&rsquo;innocuit&eacute; des traitements de premi&egrave;re intention types (radioth&eacute;rapie et\/ou t&eacute;mozolomide) chez les personnes &acirc;g&eacute;es, une population pour laquelle on a souvent limit&eacute; les traitements par crainte de leurs effets toxiques. Les patients qui ne r&eacute;agissent pas favorablement aux traitements existants ont grandement besoin de strat&eacute;gies th&eacute;rapeutiques efficaces. Pour ce faire, des chercheurs s&rsquo;emploient actuellement &agrave; &eacute;tudier le r&ocirc;le du t&eacute;mozolomide dans le cadre de traitements plus intensifs, l&rsquo;utilisation du bevacizumab et le r&ocirc;le de nouvelles cibles mol&eacute;culaires."}